Benitec Biopharma Inc. Common Stock (NASDAQ: BNTC) last traded at $8.82, down 0.56% on the session. The quote above updates while this page is open; the figures below are drawn from Benitec Biopharma Inc. Common Stock’s own filings and are restated only when a new one is published.
Benitec Biopharma Inc. Common Stock trades on NASDAQ under the ticker BNTC. Its market capitalisation is $307.67 million.
Valuation measures for Benitec Biopharma Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $307.67M |
|---|---|
| Enterprise value | $133.30M |
| Price / book | 1.74 |
| Beta | 1.57 |
Trailing-twelve-month figures tagged in Benitec Biopharma Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$45.55M |
| EPS (TTM) | -$0.980 |
|---|
| Return on equity | -25.73% |
|---|
| Cash | $179.97M |
|---|
Range and volume for BNTC over the past 52 weeks.
| 52-week high | $16.76 |
|---|---|
| 52-week low | $8.52 |
| Volume | 1.4K |
| Average volume | 152.3K |
| Previous close | $8.87 |
Invest a chosen dollar amount in Benitec Biopharma Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BNTC.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.